227 related articles for article (PubMed ID: 28780363)
1. Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation.
Kuklinski LF; Li S; Karagas MR; Weng WK; Kwong BY
J Am Acad Dermatol; 2017 Oct; 77(4):706-712. PubMed ID: 28780363
[TBL] [Abstract][Full Text] [Related]
2. Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients.
Wojenski DJ; Bartoo GT; Merten JA; Dierkhising RA; Barajas MR; El-Azhary RA; Wilson JW; Plevak MF; Hogan WJ; Litzow MR; Patnaik MM; Wolf RC; Hashmi SK
Transpl Infect Dis; 2015 Apr; 17(2):250-8. PubMed ID: 25661996
[TBL] [Abstract][Full Text] [Related]
3. Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation.
Leisenring W; Friedman DL; Flowers ME; Schwartz JL; Deeg HJ
J Clin Oncol; 2006 Mar; 24(7):1119-26. PubMed ID: 16461782
[TBL] [Abstract][Full Text] [Related]
4. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
5. Voriconazole exposure and risk of cutaneous squamous cell carcinoma among lung or hematopoietic cell transplant patients: A systematic review and meta-analysis.
Tang H; Shi W; Song Y; Han J
J Am Acad Dermatol; 2019 Feb; 80(2):500-507.e10. PubMed ID: 30130598
[TBL] [Abstract][Full Text] [Related]
6. Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
D'Arcy ME; Pfeiffer RM; Rivera DR; Hess GP; Cahoon EK; Arron ST; Brownell I; Cowen EW; Israni AK; Triplette MA; Yanik EL; Engels EA
JAMA Dermatol; 2020 Jul; 156(7):772-779. PubMed ID: 32401271
[TBL] [Abstract][Full Text] [Related]
7. Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients.
McLaughlin JM; Equils O; Somerville KT; Aram JA; Schlamm HT; Welch VL; Mardekian J; Barbers RG
Transpl Infect Dis; 2013 Aug; 15(4):329-43. PubMed ID: 23489832
[TBL] [Abstract][Full Text] [Related]
8. High-risk cutaneous squamous cell carcinoma in a Japanese allogeneic bone marrow transplant recipient on long-term voriconazole.
Ng W; Takahashi A; Muto Y; Yamazaki N
J Dermatol; 2017 Oct; 44(10):1152-1155. PubMed ID: 28470790
[TBL] [Abstract][Full Text] [Related]
9. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.
De Rosa N; Paddon VL; Liu Z; Glanville AR; Parsi K
JAMA Dermatol; 2019 Jun; 155(6):716-719. PubMed ID: 30865218
[TBL] [Abstract][Full Text] [Related]
10. Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients.
Vadnerkar A; Nguyen MH; Mitsani D; Crespo M; Pilewski J; Toyoda Y; Bermudez C; Kwak EJ; Silveira FP; Clancy CJ
J Heart Lung Transplant; 2010 Nov; 29(11):1240-4. PubMed ID: 20591690
[TBL] [Abstract][Full Text] [Related]
11. Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation.
Zwald FO; Spratt M; Lemos BD; Veledar E; Lawrence C; Marshall Lyon G; Chen SC
Dermatol Surg; 2012 Aug; 38(8):1369-74. PubMed ID: 22551390
[TBL] [Abstract][Full Text] [Related]
12. Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole.
Feist A; Lee R; Osborne S; Lane J; Yung G
J Heart Lung Transplant; 2012 Nov; 31(11):1177-81. PubMed ID: 22841559
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors and Outcomes of Nonmelanoma Skin Cancer in Children and Young Adults.
Huang JT; Coughlin CC; Hawryluk EB; Hook K; Humphrey SR; Kruse L; Lawley L; Al-Sayegh H; London WB; Marghoob A; Phung TL; Pope E; Gerami P; Schmidt B; Robinson S; Bartenstein D; Bahrani E; Brahmbhatt M; Chen L; Haddock E; Mansour D; Nguyen J; Raisanen T; Tran G; Travis K; Wolner Z; Eichenfield LF
J Pediatr; 2019 Aug; 211():152-158. PubMed ID: 31103258
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell Transplants.
Scott JF; Brough KR; Grigoryan KV; Muzic JG; Kim GY; Conic RRZ; Hill ST; Brewer JD; Baum CL; Litzow MR; Hogan WJ; Patnaik MS; Hashmi SK; Lazarus HM; Bordeaux JS; Thompson CL; Gerstenblith MR; Lehman JS
JAMA Dermatol; 2020 Jun; 156(6):631-639. PubMed ID: 32267479
[TBL] [Abstract][Full Text] [Related]
15. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
[TBL] [Abstract][Full Text] [Related]
16. Subsequent nonmelanoma skin cancers and impact of immunosuppression in liver transplant recipients.
Funk-Debleds P; Ducroux E; Guillaud O; Ursic-Bedoya J; Decullier E; Vallin M; Euvrard S; Pageaux GP; Boillot O; Dumortier J
J Am Acad Dermatol; 2018 Jul; 79(1):84-91. PubMed ID: 29307647
[TBL] [Abstract][Full Text] [Related]
17. Different effects of lansoprazole and rabeprazole on the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients.
Yasu T; Konuma T; Kato S; Kurokawa Y; Takahashi S; Tojo A
Ann Hematol; 2016 Oct; 95(11):1845-51. PubMed ID: 27535751
[TBL] [Abstract][Full Text] [Related]
18. Incidence and risk factors for skin cancer following lung transplantation.
Rashtak S; Dierkhising RA; Kremers WK; Peters SG; Cassivi SD; Otley CC
J Am Acad Dermatol; 2015 Jan; 72(1):92-8. PubMed ID: 25440431
[TBL] [Abstract][Full Text] [Related]
19. Nonmelanoma skin cancer after liver transplantation. Study of risk factors.
Herrero JI; España A; Quiroga J; Sangro B; Pardo F; Alvárez-Cienfuegos J; Prieto J
Liver Transpl; 2005 Sep; 11(9):1100-6. PubMed ID: 16123952
[TBL] [Abstract][Full Text] [Related]
20. Reasons for voriconazole prophylaxis discontinuation in allogeneic hematopoietic cell transplant recipients: A real-life paradigm.
Chan SY; Hughes RM; Woo K; Perales MA; Neofytos D; Papanicolaou G
Med Mycol; 2020 Nov; 58(8):1029-1036. PubMed ID: 32171012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
